AU2003270625A8 - Inhibition or activation of adam9 and adam15 for treatment of vascularization-related disease and wound healing - Google Patents

Inhibition or activation of adam9 and adam15 for treatment of vascularization-related disease and wound healing

Info

Publication number
AU2003270625A8
AU2003270625A8 AU2003270625A AU2003270625A AU2003270625A8 AU 2003270625 A8 AU2003270625 A8 AU 2003270625A8 AU 2003270625 A AU2003270625 A AU 2003270625A AU 2003270625 A AU2003270625 A AU 2003270625A AU 2003270625 A8 AU2003270625 A8 AU 2003270625A8
Authority
AU
Australia
Prior art keywords
adam15
adam9
vascularization
inhibition
activation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003270625A
Other versions
AU2003270625A1 (en
Inventor
Keisuke Horiuchi
Gisela Weskamp
Klaus Preissner
Carl P Blobel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MANNHEIM HEIDELBERG, University of
Justus Liebig Universitaet Giessen
Memorial Sloan Kettering Cancer Center
Original Assignee
MANNHEIM HEIDELBERG, University of
Justus Liebig Universitaet Giessen
Sloan Kettering Institute for Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MANNHEIM HEIDELBERG, University of, Justus Liebig Universitaet Giessen, Sloan Kettering Institute for Cancer Research filed Critical MANNHEIM HEIDELBERG, University of
Publication of AU2003270625A1 publication Critical patent/AU2003270625A1/en
Publication of AU2003270625A8 publication Critical patent/AU2003270625A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2003270625A 2002-09-11 2003-09-11 Inhibition or activation of adam9 and adam15 for treatment of vascularization-related disease and wound healing Abandoned AU2003270625A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40985802P 2002-09-11 2002-09-11
US60/409858 2002-09-11
PCT/US2003/028751 WO2004024089A2 (en) 2002-09-11 2003-09-11 Inhibition or activation of adam9 and adam15 for treatment of vascularization-related disease and wound healing

Publications (2)

Publication Number Publication Date
AU2003270625A1 AU2003270625A1 (en) 2004-04-30
AU2003270625A8 true AU2003270625A8 (en) 2004-04-30

Family

ID=31994015

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003270625A Abandoned AU2003270625A1 (en) 2002-09-11 2003-09-11 Inhibition or activation of adam9 and adam15 for treatment of vascularization-related disease and wound healing

Country Status (2)

Country Link
AU (1) AU2003270625A1 (en)
WO (1) WO2004024089A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7309487B2 (en) * 2004-02-09 2007-12-18 George Inana Methods and compositions for detecting and treating retinal diseases
JP5328155B2 (en) * 2005-02-02 2013-10-30 マクロジェニックス ウエスト， インコーポレイテッド ADAM-9 modulator
US20090220463A1 (en) * 2006-01-19 2009-09-03 Doo-Sik Kim Pharmaceutical Composition For Treating Vascular-Related Diseases Comprising Peptide
GB2453589A (en) 2007-10-12 2009-04-15 King S College London Protease inhibition
US8461310B2 (en) * 2008-02-14 2013-06-11 Gene Techno Science Co., Ltd. Anti-ADAM-15 antibodies and utilization of the same
EP2271668B1 (en) 2008-03-24 2017-12-20 Salman Rahman Adam-15 antibodies and immunogenic peptides
JP2012517821A (en) * 2009-02-19 2012-08-09 ガラパゴス・ナムローゼ・フェンノートシャップ Identification method and compound useful for diagnosis and treatment of diseases including inflammation
EP2621956A2 (en) 2010-10-01 2013-08-07 Salman Rahman Methods for the development of metzincin-selective catalytic cleft directed antibodies for therapeutic and diagnostic applications
CN111655256B (en) * 2017-10-29 2023-12-29 洪明奇 Compositions comprising ADAM9 inhibitor compounds
TWI735210B (en) * 2019-04-26 2021-08-01 中國醫藥大學 Use of adam9 inhibitor as immune modulator
CN114578052A (en) * 2022-03-08 2022-06-03 新疆医科大学第一附属医院 Application of ADAM10 in occlusive cardiovascular and cerebrovascular diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465468B1 (en) * 1999-03-22 2002-10-15 Darwin Discovery Limited Hydroxamic and carboxylic acid derivatives

Also Published As

Publication number Publication date
WO2004024089A2 (en) 2004-03-25
AU2003270625A1 (en) 2004-04-30
WO2004024089A3 (en) 2005-02-03

Similar Documents

Publication Publication Date Title
AU2003290548A8 (en) Prevention and treatment of synucleinopathic disease
FIU20060389U0 (en) Treatment of bone diseases
AU2003224788A1 (en) Method for treatment of tissue
IL174767A0 (en) Inhibition of fgrf3 and treatment of multiple myeloma
AU7186501A (en) Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
EP1480658A4 (en) Methods of treating vascular disease
SI1487541T1 (en) Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases
HUP0400024A3 (en) Combination for treatment of neoplastic diseases
AU2003270625A8 (en) Inhibition or activation of adam9 and adam15 for treatment of vascularization-related disease and wound healing
GB0211295D0 (en) Treatment of pain
AU2003217971A1 (en) Gas-plasma treatment of implants
AU2003259833A8 (en) Methods of treating neurodegenerative diseases
AU2003239184A8 (en) Treatment and inhibition of ocular infections and wounds by cap37 and cap37 peptides
GB2360453B (en) Treatment of skin conditions
AU2003213898A1 (en) Prevention and treatment of mycoplasma-associated diseases
GB0101146D0 (en) Treatment of skin conditions
AU2900100A (en) Methods for inhibiting cathepsin k activity for the treatment of diseases related to bone loss
AU2003280688A1 (en) Combination therapy of peptide vaccination and estramustine treatment
AU2003297570A1 (en) Treatment of skin diseases
IL136631A0 (en) Vip-related peptides for treatment of skin disordes
GB0223077D0 (en) Treatment of vascular diseases
NO20014476D0 (en) Treatment of hiatial hernia
AU2003229335A8 (en) Compositions and methods for treatment of wounds
GB0208183D0 (en) Treatment of skin conditions
AU2002365654A8 (en) Treatment of diseases via the skin

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase